Nutritional Intervention in Malnourished Patients With Chronic Heart Failure
NCT ID: NCT05527522
Last Updated: 2022-11-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
86 participants
INTERVENTIONAL
2019-01-01
2022-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, there is little information on the impact of nutritional intervention in malnourished patients with heart failure. Therefore, the aim of our study is to evaluate whether a specific nutritional intervention has an impact on mortality and hospitalizations, quality of life, nutritional status, and functional capacity in patient with heart failure and malnutrition.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Intervention Program in Malnourished Patients Admitted for Heart Failure
NCT01472237
Nutritional Improvement in Chronic Heart Failure Patients
NCT02599935
Nutritional Status and Prognosis in Heart Failure.
NCT01396824
Dietetics Education Focused on Malnutrition Prevention
NCT02892747
A Single-center Retrospective Cohort Study to Explore the Prognostic Significance of CONUT in Elderly CAD Patients With HFpEFand Compare CONUT With Other Objective Nutritional Indices.
NCT05586828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, the aim of this study was to evaluate whether the application of an educational and nutritional intervention in malnourished patients with heart failure improves prognosis, nutritional status, functional capacity and quality of life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Control arm: Who received the usual practice.
standard practice
The patients received the usual treatment and clinical practice
Intervention
Intervention arm: Who received an individualized diet, educational intervention with/without nutritional supplements depending on the degree of malnutrition plus usual practice
nutritional and educational intervention
individualized diet plus educational intervention with/without nutritional supplements
standard practice
The patients received the usual treatment and clinical practice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nutritional and educational intervention
individualized diet plus educational intervention with/without nutritional supplements
standard practice
The patients received the usual treatment and clinical practice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with clinical stability in the last 6 months defined as no admissions or decompensations in the last 6 months.
* Patients with malnutrition or at risk of malnutrition according to criteria established by the Mini Nutritional Assessment score (see attached).
* Patients who agree to participate in the study by signing the written informed consent after receiving verbal and written information about the study.
Exclusion Criteria
* Dialysis.
* Already receiving nutritional supplements.
* Known concomitant oncologic process or other concomitant disease with life expectancy of less than 1 year.
* Pregnant women.
* Participation in another clinical trial concurrently.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Extremadura
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carolina Ortiz Cortes
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolina Ortiz Cortés
Role: PRINCIPAL_INVESTIGATOR
Carolina Ortiz Cortés
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital San Pedro de Alcántara
Cáceres, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.